Cerivastatin-induced rhabdomyolysis

被引：31

作者：

Rodríguez, ML ^{[1
]}

Mora, C ^{[1
]}

Navarro, JF ^{[1
]}

机构：

[1] Hosp Nuestra Senor de Candelaria, Santa Cruz de Tenerife 38010, Spain

来源：

ANNALS OF INTERNAL MEDICINE | 2000年 / 132卷 / 07期

关键词：

D O I：

10.7326/0003-4819-132-7-200004040-00031

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：598 / 598

页数：1

相关论文

共 5 条

[1] BISCHOLL H, 1998, AM J CARDIOL S, V82, P18
[2] Cerivastatin
McClellan, KJ
Wiseman, LR
McTavish, D
[J]. DRUGS, 1998, 55 (03) : 415 - 420
[3] Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients
Mück, W
Mai, I
Fritsche, L
Ochmann, K
Rohde, G
Unger, S
Johne, A
Bauer, S
Budde, K
Roots, I
Neumayer, HH
Kuhlmann, J
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) : 251 - 261
[4] Cerivastatin in primary hyperlipidemia: A multicenter analysis of efficacy and safety
Stein, E
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) : 40J - 46J
[5] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor
Stein, EA
[J]. DRUGS, 1998, 56 (Suppl 1) : 25 - 31